Kezban Berberoğlu

• The Role Of PET/CT and SPECT/CT Imaging In Medical, Radiation, Surgical and Nuclear Oncology: Johns Hopkins Medical Institutes, Baltimore-USA
• Imaging and Targeting Receptors: Two Decades of Progress; Johns Hopkins Medical Institutes, Baltimore- USA.
• European School of Nuclear Medicine (ESNM), (15th Seminar)
• 15th National Congress of Turkish Society of Nuclear Medicine, Bone Mineral Densitometry Course
• 15th National Congress of Turkish Society of Nuclear Medicine, Cardiology for Nuclear Medicine
• Turkish Nuclear Medicine Association, Clinical Problem Solving in Oncology Cases
• Turkish Nuclear Medicine Association, Brain Perfusion SPECT Course
• Turkish Nuclear Medicine Association, Gated SPECT Course
• Turkish Nuclear Medicine Association, Nuclear Cardiology: Basic Concepts and Clinical Applications Course
• I. U. Oncology Institute, Department of Pediatric Oncology, Training Course After Graduation Diagnostic Approach Training Course in Childhood Cancers
• Turkish Nuclear Medicine Association, Basic Radio-pharmacy Course
• EANM Learning Course on PET/CT in Oncology, 27-28 August, 2005
• SNM CT Case Review Workshop, Philadelphia PA, 10 June - 10 July 2007
• Integrated Administration System Course, Certificate No. 3398, 12 December 2005
• Nuclear Medicine Business Management Program, Siemens Academy, 2007
• Taking role in JCI accreditation process and reaccreditation process
• Correlative Imaging and Reporting Course, Isparta, 25-27 February 2011
• Patient Focused Care, Leadership Training; Susan B. Frampton, Ph. D.  President of Planetree
• Advancing Patient-Centered Care. 23 April 2016

International Publications

1. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. Eroglu A1, Mudun A, Berberoğlu  K, Asoğlu  O, Özmen V, Müslümanoğlu M, Bozfakioğlu Y, Yavuz E, Tuzlalı S, Cantez S. Clin Nucl Med. 2004 May; 29(5):306-11.

2. Acute pulmonary embolism due to hydatid cyst. Türkmen C1, Unal SN, Berberoğlu K, Gençhellaç H, Unal Z, Cantez S. Clin Nucl Med. 2004 Nov;29 (11):760-1.

3. Primary lymphoma of the small bowel detected with red blood cell scintigraphy. Sanli Y1, Adalet I, Türkmen C, Kapran Y, Berberoğlu  K, Cantez S. Clin Nucl Med. 2005 Jul;30(7):490-1.

4. Role of 99mTc-hexakis-2-methoxyisobutylisonitrile for detecting marrow metastases in childhood solid tumours.  Berberoğlu K1, Ünal SN, Kebudi R, Türkmen C, Cantez S. Nucl Med Commun. 2005 Dec;26(12):1075-80.

5. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labeled leucocyte scanning. Ertugrul MB1, Baktiroğlu S, Salman S, Ünal S, Aksoy M, Berberoğlu  K, Calangu S. Diabet Med. 2006 Jun;23(6):649-53.

6. The value of combined peritumoral and subdermal injection techniques for lymphoscintigraphy in detection of sentinel lymph node in breast cancer. Sanli Y1, Berberoğlu  K, Türkmen C, Özmen V, Müslümanoğlu M, Igci A, Asoğlu  O, Kecer M, Tuzlalı S, Cantez S, Mudun A. Clin Nucl Med. 2006 Nov;31(11):690-3.

7. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors. Erten N1, Saka B, Berberoğlu  K, Türkmen C, Ünal S, Bakir B, Yekeler E, Besisik SK. Ann Hematol. 2007 Nov;86(11):805-13. Epub 2007 Aug 8.

8. Pathogens isolated from deep soft tissue and bone in patients with diabetic foot infections. Ertugrul MB1, Baktiroglu S, Salman S, Ünal S, Aksoy M, Berberoğlu  K, Calangu S. J Am Podiatr Med Assoc. 2008 Jul-Aug;98(4):290-5.

9. [18F]FDG hot spot in lung disappearing on repeat study. Dogan AS1, Berberoğlu  K. Nuklearmedizin. 2008;47(4):N37.

10. False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission. Çorapçıoğlu F, Öncel S, Berberoğlu K, Klç SC, Aydoğan A, Doğan S. J Pediatr Hematol Oncol. 2009 Jan;31(1):74-5. doi:10.1097/MPH.0b013e31818bba1b.

11. Contribution of PET-CT to staging, gross tumor volume definition, planning and response assessment in IMRT for nasopharyngeal carcinoma. Metin Güdena1, Cemile Ceylan, Kezban Berberoğlu a2, Semih Doğana2, Nadir Küçüka1, Hande Başa1, Ayhan Kılıça1 and Kayıhan Engina1 Journal of Radiotherapy in Practice 10(04):272 - 282 · December 2011.

12. Robotic Radiosurgery for Liver Metastases. Kayihan Engin , Nadir Kucuk , Murat Dökdök , Tayfun Enunlu , Kezban Berberoğlu  , Hande Baş. Ayata , Cemile Ceylan , Ayhan Kılıç , Metin Güden. Cureus. December 11, 2012. DOI: 10.7759/cureus.77.

13. PET-CT and CT Alone Comparison for Target Volume Definition in Radiation Treatment in Patients with Lung Cancer. Hande Baş Ayata, Metin Güden, Kezban Berberoğlu, Cemile Ceylan, Ayhan Kılıç, Kayıhan Engin.  International Journal of Engineering Research & Science (IJOER) ISSN: [2395-6992] [Vol-2, Issue-3 March- 2016].

National Publications

1. PET's location in monitoring of the response to chemotherapy. Kezban Berberoğlu, Remission, current oncology journal, Year 2005, volume 7, issue 4.

2. PET Remission in Radiotherapy Planning, Current Oncology Journal, Year 2005, volume 7, issue 4.

3. Comparison of PET-CT and CT images in determining target volume in patients with pulmonary tumors. Hande Baş Ayata,1 Metin Güden,1 Kezban Berberoğlu,2 Nadir Küçük,1 Cemile Ceylan,1 Ayhan Kılıç,1 Semih Doğan,2 Kayıhan Engin. Turkish Oncology Journal 2010, Volume 25, Issue 1, Page(s) 011-019.

4. Use Of Pet In Radiationtreatment Planning For Thoracic Malingnancies. Kezban Berberoğlu. Thoracic Surgery Bulletin, June 2015, Volume 6, pp 192-206; doi:10.5152/tcb.2015.061.

5. Use of PET/CT in Radiation Treatment Planning for Lung Cancer. Kezban Berberoğlu. Molecular Imaging and Radinulide Therapy 2016; 25:50-62.

Book authorship

1. PET/CT in Oncology Editor: Prof. Dr. Berna Pollack

2. PET/CT Use in Radiotherapy Planning 

International proceedings

1. Berberoğlu K., Mudun A., Tas F., Çamlıca H., Demirkürek C., Karman R., Cantez S., Kurul S. Interval lymph nodes in melanoma: true or false ? 5th International congress of Nuclear Oncology. 1-5 May 2002 Kuşadası. Turk J Nucl Med 2002; 11:9.

2. Berberoğlu K., Mudun A., Taş F., Çamlıca H., Demirkürek C., Karaman R., Cantez S., Kurul S. Melanoma of the trunk: Are unexpected lymphatic drainage patterns related to the site on the trunk? European Association of Nuclear Medicine Congres, 31 August- 4 September 2002, Vienna- Eur J Nucl Med 2002; 29:S99 (oral presentation).

3. Eroğlu A., Mudun A., Berberoğlu K, Asoğlu O, Özmen V, Müslümanoğlu M, Bozfakioğlu Y., Cantez S. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. 5th International Congress of Nuclear Oncology. 1-5 May 2002 Kuşadası. Turk J Nucl  Med 2002; 11:9.

4. Mudun A., Eroğlu A., Berberoğlu K., Asoğlu O., Özmen V., Müslümanoğlu M., Bozfakioğlu Y., Cantez S. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. 8th Congress of the World Federation of Nuclear medicine & Biology, Santiago, Chile 29 September-October 2002.:World Journal of Nuclear medicine 2002; 1: S123.

5. Berberoğlu K., Türkmen C., Ünal S., Kebudi R., Ayan İ., Taşçıoğlu C., Saka B., Beşışık S., Erten N., Cantez S. Potential role of Tc-99m MIBI for detecting bone marrow  metastases in adult and childhood malignancies. European Association of Nuclear Medicine Congress, 23-27 August, 2003 Amsterdam. Eur J Nucl Med 30: 285, 2003.

6. Cemile Ceylan, Metin Güden, Hande Baş Ayata, Kezban Berberoğlu , Ayhan Kılıç, Kayıhan Engin. PET/CT Guided IMRT for Locally Advanced Pancreatic Cancer. ESTRO-2011, poster proceeding.

7. Necdet Üskent, Muzaffer Sezer, K. Berberoğlu. Anti-idiotypic vaccine Racotumomab against NGcGM3 gangloside stabilize disease in rapidly progressing treatment refractory metastatic breast cancer .13th Annual Meeting, May 11-13, 2015. Rheingoldhalle Congress Center Mainz, Germany.

8. A. Serap Yalın, Erdem Türemen, Mithat Bıyıklı, Omer Aydıner, Özgür Sarıca, Saime Ramadan, Kezban Berberoğlu . European Congress of Endocrinology, 16-20 May 2015, Dublin, Irealand.

9. Hande Baş, Metin Güden, Kezban Berberoğlu, İbrahim Egehan, Nadir Küçük, Cemile Ceylan, Ayhan Kılıç, Kayıhan Engin. PET-CT and CT alone comparison for target volume definition in radiation treatment in patients with lung cancer.

10. Saime Sezgin Ramadan, O. Yapıcıer, K. Berberoğlu , M Sezer, H. Onat, Z Gülbaş. Bone marrow metastasis of signet ring cell carcinoma with an unknown primary site.24th European Congress of Pathology.

National Proceedings

1. Berberoğlu K., Mudun A., Müslümanoğlu M., İğci A., Yavuz E., Tokmak H., Şanlı Y., Tuzlalı., İplikçi A., Cantez S. The Effectiveness of Combined Subdermal and Peritumoral Technique in Detection of Sentinel Lymph Nodule by Lymphoscintigraphy in Early Breast Cancer. 16th National Nuclear Medicine Congress, 10-14 May 2003, Samsun. Turkish Nuclear Medicine Journal, 2003: 12:37

2. Saygılı Y., Çelik A., Tokmak H., Berberoğlu K., Şanlı Y., Kurul S.,Cantez S., Mudun A.  In Malignant Melanoma the Factors Increasing Success in Lymphoscintigraphy and Sentinel Lymph Node Biopsy Method with Gamma Probe.   16. 16th National Nuclear Medicine Congress, 10-14 May 2003, Samsun.Turkish Nuclear Medicine Journal, 2003: 12: 44.

3. Çelik A., Saygılı Y., Berberoğlu K., Tokmak H., Şanlı Y., Cantez S., Mudun A. In Breast Cancer the Factors Increasing Success in Lymphoscintigraphy and Sentinel Lymph Node Biopsy Method. 16th National Nuclear Medicine Congress, 10-14 May 2003, Samsun. 2003, 12: 44.

4. Şanlı Y., Umman B., Mudun A., Adalet I., Ünal S., Cantez S., Tokmak H., Berberoğlu K., Türkmen C. Investigation of the Relationship Between Risk Factors and False Positive Myocardial Perfusion SPECT Perfusion Defects. XVI. National Nuclear Medicine Congress, 10-14 May 2003, Samsun. 12 (1): 51, 2003.

5. Berberoğlu  K, Doğan AS, Güden M, Ceylan C, Küçük N, Engin K. Results of density-adjusted radiotherapy (YART) planning with PET / CT in 5 cases with head and neck cancer. Nuclear Medicine PET Symposium 30 April -3 May 2005 Ankara.

6. Radiotherapy planning procedure with PET / CT, Sayın S, Sağdıç N, Doğan C, Baş H, Berberoğlu K, Doğan AS, Engin K. Nuclear Medicine PET Symposium 30 April -3 May 2005 Ankara.

7. Güden M., Baş H, Berberoğlu K, Ceylan C., Küçük N., Kılıç A., Egehan İ., Engin K. Comparisons of esophageal doses to 18FDGPET-CT simulator and CT scans in patients with pulmonary tumors treated with primary RT. VII. National Radiation Oncology Congress, 19-23 April 2006 Poster presentation 008. Congress booklet, pages 85-86. 

8. Baş H, Güden M., Berberoğlu K, Ceylan C., Küçük N., Kılıç A., Egehan İ., Engin K. The importance of CT and FDG PET / CT image matching in the identification of target and critical organs in pulmonary tumors. VII. National Radiation Oncology Congress, 19-23 April 2006 Verbal Proceedings Congress booklet, pages 77-78.

9. Güden M., Baş H, Berberoğlu K, Ceylan C., Küçük N., Kılıç A., Egehan İ., Engin K. Comparisons of Medulla Spinalis doses to F 18 FDG PET-CT Simulator and Computed Tomography Planning in Patients with Pulmonary Tumors Treated with Primary Radiotherapy. VII. National Radiation Oncology Congress, 19-23 April 2006 Poster presentation 009. Congress booklet, pages 84-85.

10. Ceylan C., Güden M., Berberoğlu K., Doğan A. S., Baş H., Kılıç A., Küçük N. & Engin K.: Contribution of FDG-PET / CT imaging in determining target volume and treatment planning in nasopharynx patients who are applied Intensity Modulated Radiation Therapy - evaluation of our first 14 patients. 21st National Nuclear Medicine Congress, 2-5 May 2009, Verbal proceeding. Turkish Journal of Nuclear Medicine, 18 (1), pp.6; 2009.

11. Ceylan C., Güden M., Baş Ayata H., Küçük N., Berberoğlu K. & Engin K.: The contribution of PET-CT to target volume definition and treatment planning in nasopharyngeal cancer patients treated with IMRT – Early outcome evaluation with PET-CT scanning. 9. National Radiation Oncology Congress (UROK 2010); Abstract Book: pp. 132; April 21 – 25, 2010; Turkish Republic of Northern Cyprus, 2010.

12. Kezban Berberoğlu, Saime Sezgin Ramadan, Kemal Raşa, Özlem Yapıcıer, Metin Çakmakçı. Contribution of FDG_PET / BT to Axillary Staging in Early Stage Breast Cancer. 23rd National Nuclear Medicine Congress, UNTK 2011, verbal presentation.

13. Saime Sezgin Ramadan, Özlem Yapıcıer, Ömer Aydıner, Kutlay Karaman, Kezban Berberoğlu, Kemal Raşa, Muzaffer Sezer, Haluk Onat, Metin Çakmakçı. Primer Good Difference Neuroendocrine Carcinoma Presenting with Multiple Liver Abscess: Case Report and Literature Repeating. 21. Poster proceeding in National Pathology Congress.

14. Berberoğlu K., Küçük N., Güden M., Engin K. Evaluation of cyber knife radiotherapy-treated liver metastases by FDG-PET / CT 24th National Nuclear Medicine Congress, UNTK 2012. Poster presentation, PS61.

Speeches

1. Tehran University of Medical Sciences (TUMS) Nuclear Medicine Research Centre and Cancer Institute. Tuesday 11 May 2010 (21 Ordibehesht 1389) 10:00-10:45 AM Lecture Dr. Kezban BERBEROĞLU PET/CT IN ONCOLOGY

2. ISTANBUL CYBERKNIFE COALITION - Use of CK in Lung Cancer -10 June 2011- Speaker

3. Role of PET in CK applications - Recommendations:  Dr. Kezban Berberoğlu-Anadolu Medical Center 

4. Anadolu Medical Center Oncological Sciences Symposium: Developments in diagnosis and treatment of rectum cancer, Spec. Dr. Kezban Berberoğlu: Role of PET / CT in rectal tumors 23.06.2012.

5. Multidisciplinary Comprehensive Approach to Cancer; Tiblis, Georgia. 15 June 2013.

6. Differentiated Thyroid Cancer: Initial Management and Radioiodine Therapy. Tiblis, Georgia. 11 Sep. 2014.

7. PET/CT Use in Radiotherapy Planning - Case presentations  27th National Nuclear Medicine Congress, time 14.00 -15.00; Adana 03.04.2015.

Congresses

1. 5th International Congress of Nuclear Oncology. 1-5 May 2002 Kuşadası.

2. 15th Annual Congress of the European Association of Nuclear Medicine, 31 August- 4 September 2002, Vienna.

3. 16. 16th National Nuclear Medicine Congress, 10-14 May 2003, Samsun.

4. Nuclear Medicine PET Symposium 30 April -3 May 2005 Ankara.

5. 18th Annual Congress of the European Association of Nuclear Medicine, 15-19 October 2005, Istanbul.

6. 7th International Congress of Nuclear Oncology&18th National Congress of The Turkish Society of Nuclear Medicine. 13-17 May 2006.

7. Gastrointestinal Cancers Symposium 23-24 March 2007, Istanbul.

8. PET and Molecular Imaging in Clinical Oncology Symposium. 7-9 December 2007, Ankara.

9. Istanbul Breast Cancer Conference and National Breast Cancer Consensus Meeting. 21-25.10.2008, Istanbul.

10. PET/CT in Clinical Oncology: Evaluation of the Response to Treatment. 21 November 2008, İzmir.

11. 21st National Nuclear Medicine Congress, 2-5 May 2009, Antalya.

12. 22nd Annual Congress of the European Association of Nuclear Medicine, 10-14 October 2009, Barcelona.

13. 23rd National Nuclear Medicine Congress, 27 April - 01 May 2011, İzmir.

14. Thyroid Cancer Diagnosis and Treatment Symposium. 23-25 September 2011, Ankara.

15. 1st Balkan Congress of Nuclear Medicine. 4-8 April 2012, Antalya.

16. 25th Annual Congress of the European Association of Nuclear Medicine, 27-31 October 2012, Milan.

17. Nuclear Cardiology Symposium. 12-13 December 2014, Istanbul.

18. 26th National Nuclear Medicine Congress, 16-20 April 2014, Antalya.

19. 27th National Nuclear Medicine Congress, 01-05 April 2015, Adana.

20. New Horizons in Oncology: Breast Cancer, 12th September 2015

21. 27th National Nuclear Medicine Congress, 06-10 April 2016, İzmir.